Select Medical Holdings Co. (SEM) Receives $19.60 Consensus Target Price from Analysts

Select Medical Holdings Co. (NYSE:SEM) has received a consensus rating of “Hold” from the ten brokerages that are covering the firm, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell recommendation, three have given a hold recommendation and four have given a buy recommendation to the company. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $19.60.

SEM has been the subject of several recent analyst reports. Zacks Investment Research upgraded shares of Select Medical from a “sell” rating to a “hold” rating in a research note on Tuesday, November 7th. ValuEngine upgraded shares of Select Medical from a “hold” rating to a “buy” rating in a research note on Friday, September 1st. Royal Bank of Canada reiterated a “buy” rating and issued a $19.00 price objective on shares of Select Medical in a research note on Wednesday, September 13th. Robert W. Baird set a $25.00 price objective on shares of Select Medical and gave the company a “buy” rating in a research note on Monday, October 23rd. Finally, Deutsche Bank reiterated a “buy” rating and issued a $22.00 price objective on shares of Select Medical in a research note on Monday, November 6th.

Shares of Select Medical (NYSE:SEM) traded up $0.15 during midday trading on Thursday, hitting $16.55. 546,044 shares of the company traded hands, compared to its average volume of 891,514. The company has a debt-to-equity ratio of 3.36, a current ratio of 1.51 and a quick ratio of 1.51. Select Medical has a 12-month low of $12.00 and a 12-month high of $19.77. The firm has a market capitalization of $2,238.22, a PE ratio of 21.17, a price-to-earnings-growth ratio of 1.31 and a beta of 1.35.

Select Medical (NYSE:SEM) last announced its quarterly earnings data on Thursday, November 2nd. The health services provider reported $0.14 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.16 by ($0.02). Select Medical had a net margin of 2.21% and a return on equity of 11.44%. The company had revenue of $1.10 billion during the quarter, compared to analyst estimates of $1.10 billion. During the same quarter last year, the business earned $0.06 EPS. The firm’s revenue for the quarter was up 4.1% on a year-over-year basis. research analysts forecast that Select Medical will post 0.85 earnings per share for the current fiscal year.

In other Select Medical news, insider Martin F. Jackson sold 156,603 shares of Select Medical stock in a transaction dated Wednesday, December 13th. The shares were sold at an average price of $17.06, for a total transaction of $2,671,647.18. Following the completion of the transaction, the insider now owns 1,790,601 shares in the company, valued at $30,547,653.06. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Scott A. Romberger sold 5,000 shares of Select Medical stock in a transaction dated Wednesday, November 29th. The stock was sold at an average price of $17.97, for a total transaction of $89,850.00. Following the transaction, the insider now owns 168,211 shares of the company’s stock, valued at approximately $3,022,751.67. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 180,103 shares of company stock valued at $3,112,442. 19.93% of the stock is currently owned by company insiders.

Institutional investors and hedge funds have recently made changes to their positions in the business. Parametric Portfolio Associates LLC raised its position in Select Medical by 3.0% during the second quarter. Parametric Portfolio Associates LLC now owns 390,052 shares of the health services provider’s stock worth $5,987,000 after acquiring an additional 11,245 shares during the last quarter. Russell Investments Group Ltd. raised its position in shares of Select Medical by 121.5% in the second quarter. Russell Investments Group Ltd. now owns 85,912 shares of the health services provider’s stock valued at $1,319,000 after buying an additional 47,131 shares during the last quarter. Parametrica Management Ltd acquired a new position in shares of Select Medical in the third quarter valued at approximately $653,000. Chicago Equity Partners LLC acquired a new position in shares of Select Medical in the third quarter valued at approximately $1,105,000. Finally, Northern Trust Corp raised its position in shares of Select Medical by 14.6% in the second quarter. Northern Trust Corp now owns 2,325,289 shares of the health services provider’s stock valued at $35,694,000 after buying an additional 296,087 shares during the last quarter. Institutional investors own 77.89% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Select Medical Holdings Co. (SEM) Receives $19.60 Consensus Target Price from Analysts” was originally posted by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this piece of content on another publication, it was illegally stolen and republished in violation of U.S. & international copyright & trademark law. The legal version of this piece of content can be accessed at https://stocknewstimes.com/2018/01/11/select-medical-holdings-co-sem-receives-19-60-consensus-target-price-from-analysts.html.

About Select Medical

Select Medical Holdings Corporation is an operator of specialty hospitals, outpatient rehabilitation clinics and occupational medicine centers in the United States. The Company’s segments include specialty hospitals, outpatient rehabilitation, Concentra and Other. The specialty hospitals segment consists of hospitals designed to serve the needs of long term acute patients and hospitals designed to serve patients that require intensive medical rehabilitation care.

Analyst Recommendations for Select Medical (NYSE:SEM)

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply